New developments in hypoxia-directed patient selection and stratification in radiotherapy

Area of Science:

• Oncology
• Radiotherapy
• Hypoxia Research

Background:

• Tumor hypoxia is a known negative prognostic factor, leading to resistance to radiotherapy.
• Previous hypoxia intervention strategies have yielded limited clinical impact due to modest benefits in unselected populations and increased toxicity.
• Post-hoc analyses suggest benefits of hypoxia intervention are most pronounced in patients with highly hypoxic tumors.

Purpose of the Study:

• To review the design and outcomes of recent interventional trials utilizing tumor hypoxia biomarkers for patient selection or stratification.
• To highlight the advancements in hypoxia-directed radiotherapy driven by these emerging clinical trials.

Main Methods:

• Review of recent interventional clinical trials incorporating patient selection or stratification based on tumor hypoxia biomarkers.
• Analysis of trial designs focusing on dose modification and drug-induced tumor reoxygenation or radiosensitization.

Main Results:

• Emergence of interventional trials with patient selection based on hypoxia biomarkers.
• Investigation into dose distribution modifications and drug-induced tumor reoxygenation/radiosensitization.
• Encouraging preliminary results from some selected patient approaches.

Conclusions:

• Recent trials using hypoxia biomarkers are paving the way for improved radiotherapy.
• These studies demonstrate the potential to change clinical practice by targeting specific patient groups.
• The success of these trials sets a precedent for future hypoxia-directed radiotherapy research and development.